U.S. markets close in 3 hours 41 minutes

Tandem Diabetes Care, Inc. (TNDM)

NasdaqGM - NasdaqGM Precio en tiempo real. Divisa en USD.
Añadir a la lista de seguimiento
35.40-0.80 (-2.21%)
A partir del 12:18PM EDT. Mercado abierto.

Tandem Diabetes Care, Inc.

12400 High Bluff Drive
San Diego, CA 92130
United States
858 366 6900
https://www.tandemdiabetes.com

Sector(es)Healthcare
IndustriaMedical Devices
Empleados a tiempo completo2,400

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. John F. SheridanPresident, CEO & Director988.35kN/D1955
Ms. Leigh A. VossellerExecutive VP, CFO & Treasurer543.38kN/D1974
Ms. Susan M. MorrisonExecutive VP & Chief Administrative Officer538.21kN/D1979
Mr. David B. Berger Esq.Transitional Advisor543.38k223.28k1970
Mr. Brian B. HansenExecutive Officer561.74kN/D1968
Ms. Elizabeth Anne GasserExecutive Vice President and Chief Strategy & Product Officer542.91kN/D1976
Mr. Mark NovaraExecutive VP & Chief Commercial Officer169.6kN/D1975
Mr. Rick A. CarpenterChief Technical OfficerN/DN/D1963
Ms. Shannon M. HansenExecutive VP, Chief Legal, Privacy & Compliance Officer and SecretaryN/DN/D1966
Mr. Tom FoxChief Human Resources OfficerN/DN/DN/D
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Gestión corporativa

La calificación ISS Governance QuickScore de Tandem Diabetes Care, Inc. a partir del 29 de abril de 2024 es 3. Las puntuaciones principales son Auditoría: 3; Junta: 1; Derechos del accionista: 4; Compensación: 5.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.